Epicrispr Biotechnologies vs Spark Therapeutics

Epicrispr Biotechnologies vs Spark Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Spark Therapeutics on 58/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
Spark Therapeutics logo
Spark TherapeuticsA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Try Spark Therapeutics

Where each one leads

Epicrispr Biotechnologies

  • our overall score: 62/100 against 58/100

Spark Therapeutics

  • domain rating: 80/100 against 40/100

At a glance

MeasureEpicrispr BiotechnologiesSpark Therapeutics
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, Gene Therapy, Healthcare, Pharmaceuticals
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20202013
HeadquartersSouth San Francisco, United StatesPhiladelphia, United States
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesSpark Therapeutics
Employees51Not published
Total funding$90.0M$82.8M
Latest roundSeries CSeries B
LinkedIn followers7,025Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesSpark Therapeutics
StartupHub scoreOur 0-100 rating62/10058/100
Traction57/10040/100
Team40/10090/100
Search visibility20/10013/100
Quality78/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (39/100)
Domain ratingLink authority, 0-10040/10080/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesSpark Therapeutics
CDNCloudflareCloudflare
CMSWordPressNot detected
FrameworksJquery, Tailwind CSS, BootstrapJquery
AnalyticsGoogle Analytics 4Google Tag Manager

What users say

MeasureEpicrispr BiotechnologiesSpark Therapeutics
Reddit sentimentThreads we trackNot published1 positive, 0 negative across 3 threads
Spark Therapeutics
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.
r/conspiracy

Epicrispr Biotechnologies vs Spark Therapeutics: common questions

Which is better, Epicrispr Biotechnologies or Spark Therapeutics?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and Spark Therapeutics compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 58/100). Spark Therapeutics leads on domain rating (80/100 against 40/100).

What do real users say about Epicrispr Biotechnologies and Spark Therapeutics?

Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.

Read the full Epicrispr Biotechnologies review and pricing or the Spark Therapeutics review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.